This information can change. Please double check resources and continue to monitor them for up to date information.
CDC Vaccine Safety Information: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/safety-of-vaccines.html
CDC Vaccine FAQ: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/faq.html
OHA Vaccine FAQ: https://sharedsystems.dhsoha.state.or.us/DHSForms/Served/le2390u.pdf
How CDC Monitors Vaccine Effectiveness info can be found here.
Have you experienced a side effect following COVID-19 vaccination?
You can report it to VAERS.
Find out more about the different vaccines, including vaccines still in the authorization process, from the CDC at this website.
Emergency Use Authorization is a tool of the FDA to speed up processes when need is urgent and there are no available alternatives. This can be used to allow drugs to be utilized a different way than previously classified and it can cut red tape for new therapies. Clinical trials must be 2 months past phase 3 studies and documentation from all phases must be included in the application for emergency use. While the requirements stipulate sample groups to include at least 3,000 people; COVID vaccination trials have included tens of thousands of people. The FDA has also made all vaccination trials information available to corollary state bodies for a simultaneous review process.